RT @NigilHaroon: #ACR16 plenary. Dr. Gensler: #AS Pts on high dose nsaid + TNF inhibitor have 60% lower risk of progression. — Nigil Haroon (@NigilHaroon) November 14, 2016
RT @NigilHaroon: #ACR16 plenary. Dr. Gensler: #AS Pts on high dose nsaid + TNF inhibitor have 60% lower risk of progression.